LeMaitre Vascular Inc (LMAT)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 25,610 | 24,269 | 19,134 | 13,855 | 26,764 |
| Short-term investments | US$ in thousands | 274,112 | 80,805 | 63,557 | 56,104 | 214 |
| Total current liabilities | US$ in thousands | 30,607 | 29,879 | 25,329 | 21,813 | 25,145 |
| Cash ratio | 9.79 | 3.52 | 3.26 | 3.21 | 1.07 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($25,610K
+ $274,112K)
÷ $30,607K
= 9.79
The cash ratio of LeMaitre Vascular Inc has shown a steady increase over the past five years, going from 1.07 in December 2020 to 9.79 in December 2024. This indicates the company's ability to cover its short-term liabilities with its readily available cash and cash equivalents has significantly improved over this period. A higher cash ratio is generally favorable as it suggests a more liquid position and better financial health, enabling the company to meet its financial obligations without relying heavily on external sources of funding. LeMaitre Vascular Inc's increasing trend in cash ratio reflects strong liquidity management and financial stability during the assessed years.
Peer comparison
Dec 31, 2024